213 related articles for article (PubMed ID: 28064545)
1. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
Mizushima T; Tirador KA; Miyamoto H
Expert Opin Ther Targets; 2017 Mar; 21(3):249-257. PubMed ID: 28064545
[TBL] [Abstract][Full Text] [Related]
2. Role of the androgen receptor in urothelial cancer.
Inoue S; Mizushima T; Miyamoto H
Mol Cell Endocrinol; 2018 Apr; 465():73-81. PubMed ID: 28652170
[TBL] [Abstract][Full Text] [Related]
3. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of the androgen receptor in bladder cancer.
Lombard AP; Mudryj M
Endocr Relat Cancer; 2015 Oct; 22(5):R265-77. PubMed ID: 26229034
[TBL] [Abstract][Full Text] [Related]
5. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
Garcia PV; Apolinário LM; Böckelmann PK; da Silva Nunes I; Duran N; Fávaro WJ
Int J Clin Exp Pathol; 2015; 8(5):4427-43. PubMed ID: 26191134
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Hsieh TF; Chen CC; Ma WL; Chuang WM; Hung XF; Tsai YR; Lin MH; Zhang Q; Zhang C; Chang C; Shyr CR
Oncol Rep; 2013 Dec; 30(6):2917-22. PubMed ID: 24126741
[TBL] [Abstract][Full Text] [Related]
8. The Role of Androgens and Androgen Receptor in Human Bladder Cancer.
Martínez-Rojo E; Berumen LC; García-Alcocer G; Escobar-Cabrera J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919565
[TBL] [Abstract][Full Text] [Related]
9. Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis.
Mizushima T; Jiang G; Kawahara T; Li P; Han B; Inoue S; Ide H; Kato I; Jalalizadeh M; Miyagi E; Fukuda M; Reis LO; Miyamoto H
Mol Cancer Ther; 2020 Sep; 19(9):1930-1942. PubMed ID: 32737155
[TBL] [Abstract][Full Text] [Related]
10. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
Izumi K; Ito Y; Miyamoto H; Miyoshi Y; Ota J; Moriyama M; Murai T; Hayashi H; Inayama Y; Ohashi K; Yao M; Uemura H
Oncotarget; 2016 Mar; 7(12):14153-60. PubMed ID: 26885620
[TBL] [Abstract][Full Text] [Related]
11. Androgen activates β-catenin signaling in bladder cancer cells.
Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer.
Kashiwagi E; Ide H; Inoue S; Kawahara T; Zheng Y; Reis LO; Baras AS; Miyamoto H
Oncotarget; 2016 Aug; 7(31):49169-49179. PubMed ID: 27322140
[TBL] [Abstract][Full Text] [Related]
13. Promotion of bladder cancer development and progression by androgen receptor signals.
Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C
J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone increases the risk of bladder cancer in men.
Gil D; Zarzycka M; Dulińska-Litewka J; Ciołczyk-Wierzbicka D; Lekka M; Laidler P
Hum Cell; 2019 Jul; 32(3):379-389. PubMed ID: 31119584
[TBL] [Abstract][Full Text] [Related]
15. Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.
Miyamoto H; Zheng Y; Izumi K
Curr Cancer Drug Targets; 2012 Jan; 12(1):14-22. PubMed ID: 22111835
[TBL] [Abstract][Full Text] [Related]
16. Androgens and esophageal cancer: What do we know?
Sukocheva OA; Li B; Due SL; Hussey DJ; Watson DI
World J Gastroenterol; 2015 May; 21(20):6146-56. PubMed ID: 26034350
[TBL] [Abstract][Full Text] [Related]
17. The role of the androgen receptor in the development and progression of bladder cancer.
Li Y; Izumi K; Miyamoto H
Jpn J Clin Oncol; 2012 Jul; 42(7):569-77. PubMed ID: 22593639
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
19. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
20. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
